The clearance could be a chance for the companies to bounce back after the controversial approval of their earlier Alzheimer’s drug, Aduhelm, in 2021 https://t.co/A71nE2Repk— Bloomberg (@business) January 7, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


